Participants
anxiety, post-traumatic stress disorder, PTSD, depression, DSM-5
Between March 2019 and December 2021, 758 individuals agreed to be contacted by VU of which 236 provided IC and completed screening. Thirty participants were excluded (see CONSORT (Consolidated Standards of Reporting Trials) flow diagram in CONSORT flow diagramBaseline characteristics*n=200.†Based on HSCL-25 depression subscale cut-off ≥2.10.‡Based on HSCL-25 anxiety subscale cut-off ≥2.00.§Based on PCL-5 ≥33.CAU, care as usual; HSCL, Hopkins Symptom Checklist; PCL-5, PTSD Checklist for DSM-5; PM+, Problem Management Plus; PM+/CAU, PM+ in addition to care as usual; PMLD, post-migration living difficulties; PSYCHLOPS, Psychological Outcomes Profiles; PTSD, post-traumatic stress disorder; WHODAS 2.0, WHO Disability Assessment Schedule 2.0.Retention at 3-month follow-up was 85.4%, with data available for 84 participants (81.5%) in PM+/CAU and 92 (89.3%) in CAU. Participants lost at 3-month follow-up versus those retained did not differ in terms of baseline characteristics (
In PM+/CAU, 87 participants (84.5%) attended a minimum of four PM+ sessions (see 